Stand Up To Cancer (SU2C) today announced three Research Teams focused on bringing new therapies to clinical trials for the treatment of gastroesophageal cancer (GEC).
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.
/PRNewswire/ Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after.
Nearby Healthy Tissue Genetics May Predict Lung Cancer Recurrence miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
G1 Therapeutics, Inc. (NASDAQ:GTHX – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 2,960,000 shares, a decrease of 5.1% from the May 15th total of 3,120,000 shares. Based on an average trading volume of 886,800 shares, the days-to-cover ratio is […]